Eduardo Wajnberg1, Fernanda Rueda, Edson Marchiori, Emerson L Gasparetto. 1. Médico do Serviço de Serviço de Radiodiagnóstico, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro RJ, Brasil. eduardowj@gmail.com
Abstract
OBJECTIVE: To re-enforce an alternative, less aggressive treatment modality in the management of intracranial infectious aneurysms. METHOD: We present a series of five patients with infectious endocarditis and intracranial infectious aneurysms (mycotic aneurysms) managed by means of endovascular treatment. RESULTS: Endovascular treatment was executed technically uneventfully in all patients. Three patients had favorable clinical outcome: two were classified as Glasgow Outcome Scale 4/5, and one had total neurological recovery (GOS 5/5). Two patients died (GOS 1/5), one in consequence of the initial intracranial bleeding and the other after cardiac complications from endocarditis and open-heart surgery. CONCLUSION: Endovascular techniques are an expanding option for the treatment of IIAs. It has been especially useful for infectious endocarditis patients with IIA, who will be submitted to cardiac surgery with cardiopulmonary bypass and anticoagulation, with the risk of intracranial bleeding.
OBJECTIVE: To re-enforce an alternative, less aggressive treatment modality in the management of intracranial infectious aneurysms. METHOD: We present a series of five patients with infectious endocarditis and intracranial infectious aneurysms (mycotic aneurysms) managed by means of endovascular treatment. RESULTS: Endovascular treatment was executed technically uneventfully in all patients. Three patients had favorable clinical outcome: two were classified as Glasgow Outcome Scale 4/5, and one had total neurological recovery (GOS 5/5). Two patients died (GOS 1/5), one in consequence of the initial intracranial bleeding and the other after cardiac complications from endocarditis and open-heart surgery. CONCLUSION: Endovascular techniques are an expanding option for the treatment of IIAs. It has been especially useful for infectious endocarditispatients with IIA, who will be submitted to cardiac surgery with cardiopulmonary bypass and anticoagulation, with the risk of intracranial bleeding.
Authors: Andrew F Ducruet; Zachary L Hickman; Brad E Zacharia; Reshma Narula; Bartosz T Grobelny; Justin Gorski; E Sander Connolly Journal: Neurosurg Rev Date: 2009-10-16 Impact factor: 3.042
Authors: Isabel González; Cristina Sarriá; Javier López; Isidre Vilacosta; Alberto San Román; Carmen Olmos; Carmen Sáez; Ana Revilla; Miguel Hernández; Jose Luis Caniego; Cristina Fernández Journal: Medicine (Baltimore) Date: 2014-01 Impact factor: 1.889